Durham-based Aldagen, Inc. (www.aldagen.com), a company focused on stem cell research, has received $17.3 million in debt and equity financing. The Series C equity financing was co-led by Harbert Venture Partners, LLC and Intersouth Partners. Also participating in the round were existing investors The Aurora Funds, Trelys Funds, L.P., Tall Oaks Capital Partners, Village Ventures and the Piedmont Angel Network.
The $3 million in debt financing was secured with Square 1 Bank. The Company will use these funds to advance its pipeline of regenerative medicine clinical studies.
Aldagen is a CED member.
The Aurora Funds is a CED member.
Harbert Venture Partners is
a CED member.
Intersouth Partners is a CED
member.
Square 1 Bank is a CED member.
Tall Oaks Capital Partners is
a CED member.
Trelys Funds is a CED member.